Patent · US Active

Immunogenic WT-1 peptides and methods of use thereof

US9919037B2 · kind B2 · utility

2Cited by

56References

15Claims

0Family size

Assignee

Memorial Sloan Kettering Cancer Center · US

Inventors

David A. Scheinberg · New York, US
Tao Dao · New York, US

Key dates

Filing date	Jan 15, 2014
Grant date	Mar 20, 2018
Priority date	—
Expiry date	Jan 15, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides peptides, immunogenic compositions and vaccines, and methods of treating, reducing the incidence of, and inducing immune responses to a WT1-expressing cancer, comprising heteroclitic peptides derived from the WT-1 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.